|1.||Cruikshank, William W: 4 articles (12/2011 - 07/2003)|
|2.||Center, David M: 3 articles (12/2011 - 02/2004)|
|3.||Richmond, Jillian: 2 articles (12/2011 - 10/2011)|
|4.||Zhang, Yujun: 2 articles (12/2011 - 02/2004)|
|5.||Kornfeld, Hardy: 2 articles (09/2005 - 03/2005)|
|6.||Ren, Fucheng: 2 articles (09/2005 - 03/2005)|
|7.||Kim, J: 1 article (03/2013)|
|8.||Choe, C-H: 1 article (03/2013)|
|9.||Kim, S-H: 1 article (03/2013)|
|10.||Jang, Y-S: 1 article (03/2013)|
|1.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/01/2004 - "In this study we have found that pro-IL-16 is absent or mutated in four T lymphoblastic leukemia cell lines examined. "
12/01/2011 - "T cells isolated from 11 patients with advanced CTCL, but not those from healthy controls or patients with T cell acute lymphocytic leukemia (T-ALL), demonstrated reduction in nuclear pro-IL-16 levels. "
|2.||Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/01/2011 - "Therefore, we tested whether or not reintroduction of pro-IL-16 into solid tumors in mice could halt tumor growth. "
03/01/2005 - "Pro-IL-16 expressed in transfected tumor cells was previously shown to translocate to the nucleus and to promote G(0)/G(1) arrest by stabilizing the cyclin-dependent kinase inhibitor p27(Kip1). "
|4.||Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
|5.||T-Cell Lymphoma (Lymphoma, T Cell)
03/01/2013 - "Given that IL-16 acts as an immunomodulator by impairing antigen-induced T cell activation and its precursor, pro-IL-16, plays a role in regulating the cell cycle in T lymphocytes and T cell lymphoma, we concluded that pro-IL-16 is involved in resting B cell proliferation, similar to its function in T lymphocytes."
|1.||Cyclin-Dependent Kinase Inhibitor p27
|2.||Untranslated Regions (Untranslated Region)
|3.||3' Untranslated Regions (3' UTR)
|4.||5' Untranslated Regions (5' UTR)
|5.||Interleukin-16 (Interleukin 16)
|6.||Complementary DNA (cDNA)